Jared Berberabejared.berberabe@bioinfoinc.comBiosensorsSaliva-based graphene sensor shows high sensitivity in preliminary studiesIdentifySensors Biologics is developing saliva-based digital graphene nanosensor technology that it believes can be more sensitive than PCR in detecting COVID-19.December 12, 2022COVID-19Exposure to SARS-CoV-2 vaccination and infection may provide more durable immunity: Canadian studyExposure to vaccination and infection "likely provides stronger, broader, and more durable hybrid immunity than either exposure alone, especially against severe outcomes,” the researchers said.December 6, 2022Lung CancerUniversity of Louisville developing experimental approach for lung cancer breath testA research group is leveraging measurements of volatile organic compounds and machine learning to develop a test that detects lung cancer.December 2, 2022Heart Disease‘Good’ cholesterol worse for some adults: NIH studyIn the study, lower levels of "good" cholesterol were associated with increased risks for heart attacks for white but not Black adults.November 23, 2022Breast CancerNetherlands study finds blood protein level changes two years prior to breast cancer diagnosisThe study found that prior to being diagnosed with breast cancer, women may experience changes in the levels of certain proteins found in the bloodstream, leading to the potential for early detection using blood tests.November 16, 2022Kidney DiseaseUniversity of Tokyo researchers developing noninvasive method for early detection of childhood chronic kidney diseaseBy analyzing the variations in protein levels in collected urinary extracellular vesicles, the researchers believe they have discovered a first-step approach that could lead to earlier diagnosis of the disease in children.November 9, 2022Heart FailureRoche points to results of heart failure study leveraging its cardiac hormone biomarker and testThe results were shared this week at an American Heart Association Late-Breaking Scientific Session and published simultaneously in the Lancet.November 9, 2022Aortic AneurysmACC, AHA issue aortic disease guideline, recommend genetic screeningThe guidelines include genetic testing of first-degree relatives of individuals with thoracic aortic disease, as well as an emphasis on surgical thresholds, imaging, and multidisciplinary aortic teams.November 3, 2022COVID-19UK Biobank study links COVID-19 infection with poor cardiovascular healthIndividuals who have been hospitalized because of COVID-19 infection have a higher risk of experiencing adverse cardiovascular health outcomes, according to a UK Biobank study.October 27, 2022COVID-19UCLA research shows rapid antigen tests may be effective tools for return-to-work programsResearchers from UCLA conducted a study examining how antigen test results may be used to guide healthcare systems implementing return-to-work protocols.October 24, 2022Page 1 of 3Next PageTop StoriesCancerInvivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detectionUnder the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.Regulatory ApprovalSeegene obtains IVDR certification for 30 diagnostic assaysPolicy and RegulationAdvocacy groups in letter urge FDA to develop regulations for lab-developed testsCollaborationNucleai, Adlai Nortye collaborate on biomarkers for clinical trialsSponsor ContentVisit our Molecular Diagnostics Community
